Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “buprenorphine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 52
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 52 pipeline programs matching "buprenorphine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

52 results for “buprenorphine” Back to intelligence hub

Search results

Page 1 of 3
  1. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 3 small molecule completed

    5 trials
  2. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 3 small molecule completed

    2 trials
  3. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 3 small molecule active

    1 trial
  4. Buprenorphine + Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 3 small molecule completed

    1 trial
  5. Buprenorphine +OTP

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Addiction

    phase 3 small molecule completed

    1 trial
  6. Buprenorphine Injection

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 3 small molecule completed

    1 trial
  7. Buprenorphine Transdermal System

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Disease (or Disorder); Intervertebral Disc, With Myelopathy (Manifestation)

    phase 3 small molecule completed

    1 trial
  8. Buprenorphine/Naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 3 small molecule terminated

    1 trial
  9. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 3 small molecule terminated

    6 trials
  10. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 3 small molecule completed

    2 trials
  11. Extended Release Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorder

    phase 3 small molecule completed

    1 trial
  12. Probuphine (buprenorphine implant)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependency

    phase 3 small molecule completed

    1 trial
  13. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Addiction

    phase 2 small molecule completed

    1 trial
  14. Buprenorphine

    Indivior Pty Ltd

    Opioid Use Disorder

    phase 2 small molecule completed

    1 trial
  15. Buprenorphine Naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Maternal Opioid Use Disorder

    phase 2 small molecule completed

    1 trial
  16. Buprenorphine SL

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 2 small molecule active

    1 trial
  17. Buprenorphine and Outpatient Parenteral Antibiotic Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Use

    phase 2 small molecule completed

    1 trial
  18. Buprenorphine hydrochloride marketed sublingual tablet (Subutex)

    Indivior Pty Ltd

    Opioid Dependency

    phase 2 small molecule completed

    1 trial
  19. Buprenorphine soluble film

    Indivior Pty Ltd

    Opioid-related Disorders

    phase 2 small molecule completed

    1 trial
  20. Buprenorphine/naloxone Film Strip

    Indivior Pty Ltd

    Opioid-Related Disorders

    phase 2 small molecule completed

    1 trial
  21. buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 2 small molecule active

    1 trial
  22. buprenorphine taper followed by naltrexone maintenance

    BRIGHT MINDS BIOSCIENCES INC.

    Prescription Opioid Dependence

    phase 2 small molecule completed

    1 trial
  23. extended-release buprenorphine (BXR)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 2 small molecule on hold

    1 trial
  24. Buprenorphine

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.